Atlas Invest | $25,000,000 | (Jan 22, 2026)
AiStrike | $7,000,000 | (Jan 22, 2026)
Zarminali Pediatrics | $110,000,000 | (Jan 22, 2026)
Circulate
United States
- Seattle, Washington
- 04/07/2025
- Seed
- $12,000,000
We are pioneering technologies and treatments to reverse aging and improve health outcomes. Rigorous scientific research is at the core of what we do. We are committed to innovating how people live healthier and longer lives by centering our approach on extensive research and clinical trials. Therapeutic Plasma Exchange (TPE) by Circulate is an evidence-based treatment that removes toxic, inflammatory, disease-causing and age-accelerating substances from the bloodstream. Our patented flagship product is improving lives today.
- Industry Outpatient Care Centers
- Website https://www.circulate.health/
- LinkedIn https://www.linkedin.com/company/circulatehealth/
Related People
Brad YounggrenFounder
United States -
Seattle, Washington
CEO & Co-founder, Circulate
Previous Roles:
President (98point6)
Chief Medical Officer (4x) (98point6, Cue Health, Shift Labs, Mobisante)
Board Member Eastside Research Associates, Cardiogenics
Current Advisory Board: TBD Health, Violett , AlliConnect, Calmwave, 98point6
Previous Advisory role: Crescent Health (acquired) Blumio (acquired), Highway 1, Cue Med, Misceo
Emergency Physician
One to One Health | $12,000,000 | (Jan 22, 2026)
AnswersNow | $40,000,000 | (Jan 22, 2026)
Claim Health | $4,400,000 | (Jan 22, 2026)
Upscale AI(US) | $200,000,000 | (Jan 22, 2026)
Nasdaq Private Market | $37,600,000 | (Jan 22, 2026)
PraxisPro | $6,000,000 | (Jan 22, 2026)
furl | $10,000,000 | (Jan 22, 2026)
humans& | $480,000,000 | (Jan 22, 2026)
Think Bioscience | $55,000,000 | (Jan 21, 2026)